Skip to content

M B Leal

3 papers in the library · 41 citations · publishing 2000-2006

Papers

Sort Most recent Most cited

Nature-inspired indolyl-2-azabicyclo[2.2.2]oct-7-ene derivatives as promising agents for the attenuation of withdrawal symptoms: synthesis of 20-desethyl-20-hydroxymethyl-11-demethoxyibogaine.

Natural Product Research July 10, 2006 Daniele Passarella, A Barilli, Simon M. N. Efange et al. 4 citations

Microwave assisted Diels-Alder cycloaddition of 5-Br-N-benzylpyridinone (2) with methyl acrylate is described to gain an easy access to 7-bromo-2-benzyl-3-oxo-2-aza-5 or 6-carbomethoxy bicyclo[2.2.2]oct-7-enes (3)-(6). The preparation of the ibogaine analogue 20-desethyl-(20-endo)-hydroxymethyl-11-demethoxyibogaine (17) is described by stereoselective hydrogenation of the C(7)-C(8) double bond....

DOI: 10.1080/14786410500160645 (opens in new tab) Full text (opens in new tab) Addiction treatment Withdrawal management Substance abuse therapy Drug recovery +28

Ibogaine alters synaptosomal and glial glutamate release and uptake.

Neuroreport February 12, 2001 M B Leal, T Emanuelli, L D Porciúncula et al. 14 citations

Ibogaine has aroused expectations as a potentially innovative medication for drug addiction. It has been proposed that antagonism of the NMDA receptor by ibogaine may be one of the mechanisms underlying its antiaddictive properties; glutamate has also been implicated in ibogaine-induced neurotoxicity. We here report the effects of ibogaine on [3H]glutamate release and uptake in cortical and...

DOI: 10.1097/00001756-200102120-00017 (opens in new tab) Full text (opens in new tab) Ibogaine Compound Addiction treatment Safer treatment development +7

Long-lasting ibogaine protection against NMDA-induced convulsions in mice.

Neurochemical Research August 1, 2000 M B Leal, D O De Souza, E Elisabetsky 23 citations

Ibogaine, a putative antiaddictive drug, is remarkable in its apparent ability to downgrade withdrawal symptoms and drug craving for extended periods of time after a single dose. Ibogaine acts as a non-competitive NMDA receptor antagonist, while NMDA has been implicated in long lasting changes in neuronal function and in the physiological basis of drug addiction. The purpose of this study was...

DOI: 10.1023/a:1007665911622 (opens in new tab) Full text (opens in new tab) Ibogaine: ibogaine Drug withdrawal Craving Neuropharmacology: brain receptors +6